Monthly Archives: October, 2013

In Memoriam

I am listing the family, friends and fellow physicians that were lost to me and I note how grateful I am to still be alive to continue the pursuit of justice for me and others who were misdiagnosed.

William Hart MD

Robert James Provan JD

Larry Mason Lee JD

Kathy Sheley Ph D

Joshua Carreon

legal writer who was to be contracted to write my suit against the medical board in 2005

wheel chair activist recommended by Robert Provan to help advocate for ADA rights in Texas courts (died per 2005 Internet postings), subsequently discovered to not have died when I found current writings from him in a journal dated 2006

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

I only recently became aware of the controversy over the deaths of two U S Attorneys investigating healthcare fraud involving the purchasing of hospital supplies. The situation began when an independent medical supplier found he was shut out of the market by a consortium of suppliers. Thelma Quince Colbert and Shannon Ross’s unexpected deaths deserved a thorough investigation.

http://www.stewwebb.com/dead_fired_attorneys_linked_to_white_house.htm

copy of post found and placed here on October 19, 2013 as follows

Dead, fired attorneys’ Medicare fraud probe linked to White House

Senator McCaskill knew about dead attorneys before Senate Gonzales hearing

http://www.stewwebb.com

http://www.tomflocco.com/fs/FiredAttorneysFraudProbe.htm

by Tom Flocco

Lee’s Summit, Missouri—May 10, 2007—Tom Flocco.com—According to Medical Supply Chain CEO Samuel Lipari who is suing hospital supply company Novation LLC, Missouri Democratic Senator Claire C. McCaskill knew that seven U.S. attorneys—two assistants who turned up dead, three assistants who resigned or were fired and two U.S. attorneys who were also forced out—had something in common: all seven were investigating Medicare and Medicaid fraud in the United States healthcare system involving overcharging for hospital supplies and medical fees amounting to billions of dollars in fraud.

https://i2.wp.com/www.tomflocco.com/fsimage/ClaireCMcCaskill.jpg

Senator
Claire C. McCaskill
(D-MO)

Lipari’s suit against Novation has ties to the White House in that the President’s brother Jeb Bush joined the board of directors of Novation member Tenet Healthcare on April 12, 2007 and George W’s cousin’s company wrote software for hospital equipment global reference numbers, raising questions as to why Jeb Bush has become associated with a company involved in multiple lawsuits and fraud probes.

President Bush’s first cousin Jonathan Bush is CEO of Athena Health in Watertown, Massachusetts, the developer of Novation’s “CodeRyte” software program that “runs on an algorithm built into the system,” which “can read the data entry, find any required associations and automatically contact on-staff coders who can read the work and determine the appropriate code.”

Former Florida Governor Jeb Bush’s association with Novation’s Tenet Healthcare comes after Tenet was audited in 2004 by the California Department of Health Services after overcharging the state’s Medicaid program, Medi-Cal, by $11.9 million at Redding Medical Center, linked to a Tenet probe by fired San Diego U.S. Attorney Carol Lam, a 45-agent FBI raid and multiple subpoenas signed by a Dallas assistant U.S. attorney found dead the day before Senate healthcare anti-trust hearings.

San Diego and Memphis papers reported that Tenet Healthcare Corporation of Dallas has agreed to pay $21 million as part of a civil settlement with the federal government over allegations of kickbacks to doctors. The settlement also requires Tenet to close or sell the hospital where the kickbacks allegedly took place, Alvarado Hospital Medical Center in San Diego.

The settlement averts a third criminal trial over an alleged kickback scheme between 1992 and 2002 to pay doctors for referring patients to Alvarado. Two previous trials, in 2004 and 2005, ended in deadlocked juries.

https://i2.wp.com/www.tomflocco.com/fsimage/SamuelLipari.jpg

Samuel Lipari

“The implication for fraud involving hospital equipment costs, multiple fee structures and insurance claims is quite high,” alleged Lipari, after we told him that Novation was one of the first in the healthcare group purchasing industry to endorse Athena Health and Jonathan Bush’s CodeRyte Global Locator Numbers (GLN) which are 13-digit reference numbers used to identify legal entities such as registered hospitals, specific hospital departments, warehouses or particular rooms or beds in a hospital.

U.S. intelligence sources allege that electronic medical coding can be manipulated to over-bill or essentially defraud the U.S. healthcare system in the same manner as election fraud activists have proven that electronic voting machines can be manipulated to fix U.S. elections, but also vote counts in foreign countries such as last week’s French national election.

A highly placed U.S. intelligence agent was asked to inquire among other federal insiders as to the full extent of healthcare fraud over the last ten years, after which the agent later said, “Intelligence officials in a position to know have estimated the real dollar figure to be about $ .5 trillion in stolen Medicare and Medicaid funds,” adding, “healthcare entities have defrauded the United States government to the extent that the whole system faces either bankruptcy or hyper-inflated costs.”

Senate Judiciary obstruction of justice

The Senate Judiciary Committee failed to question Attorney General Gonzales about the two suspicious deaths and three abrupt departures of assistant U.S. attorneys at the Dallas-Fort Worth U.S. Justice Department (DOJ) offices all within 90 days during an $84 billion Medicare fraud probe.

The Senate’s actions raise questions as to why McCaskill failed to pass Lipari’s March 26, 2007 letter to McCaskill explaining the fraud probe over to Chairman Patrick Leahy (D-VT) prior to the April 19 Gonzales Judiciary Committee hearing.

California’s Redding Medical Center is one of thousands of U.S. hospitals, nursing homes and clinics subject to the far-reaching Justice Department Medicare fraud probe researched by Fort Worth Civil Enforcement Head Thelma Colbert which resulted in multiple subpoenas signed by her boss, Dallas U.S. Attorney’s office Criminal Chief Shannon Ross—after which Ross was found dead on September 13, 2004, the day before Senate hearings on healthcare anti-trust violations—and just 55 days after Colbert turned up dead in her swimming pool on July 20, 2004.

The Senate Judiciary Committee also failed to interrogate Gonzales about circumstances involving the quick departures (35 days after Ross’ death) of three assistant U.S. attorneys in Colbert’s Fort Worth office—Leonard Senerote, Michael Uhl and Michael Snipes—and whether the Attorney General had them fired, forced them to resign or they were intimidated by the deaths of Colbert and Ross.

Given recent lengthy prison terms for several high corporate executives, the stakes are obviously high in a healthcare fraud case with ties to the White House; but were the stakes high enough to necessitate decimating the whole civil fraud unit in Dallas-Fort Worth?

The Democratic Senate Judiciary majority failed in its oversight by never questioning the Attorney General as to why he covered up the Colbert and Ross deaths, and why Lipari’s Medicare fraud probe and the Dallas-Fort Worth subpoenas have been derailed, essentially going nowhere.

No U.S. legal entity has questioned whether McCaskill or Leahy obstructed justice in the Senate’s Gonzales hearing under 18 United States Code 4 guidelines for reporting federal crimes, or whether meritorious evidence that the White House purposely quashed the Texas fraud case was also covered up, despite deaths and firings within a compact timeline.

It is not known whether the Dallas-Fort Worth subpoenas or Lipari’s Novation suit have been totally disrupted; but the Redding Medical Center findings indicate that a probe into electronic medical coding manipulation potentially linked to Medicare and Medicaid over-billing should be ordered by Congress to protect Medicare and Medicaid for America’s seniors.

Last Thursday we talked to Senator McCaskill’s deputy chief of staff Dana Postar who said, “We will get back to you with a statement regarding the disposition of Mr. Lipari’s case and any investigation into his charges,” after we told her about the first two stories at TomFlocco.com.

The previous week we also talked to McCaskill’s press spokesperson Maria Speiser who told us, “We never received Mr. Lipari’s letter but I know about the case,” to which Lipari replied, “Senator McCaskill has the letter. In the presence of my attorney, I signed their ‘privacy waiver” seeking my signed permission for her office to commence an investigation of my case which we mailed to Sen. McCaskill’s office.”

While neither staffer has called us back with a statement, Sam Lipari told us that “Cory from Senator McCaskill’s constituent services staff called me on May 1, the day after your second story was posted online, asking ‘What can we do to help you?’ “

“Maybe Sen. McCaskill will question the Gonzales cover-up of the deaths and firings in Texas and help get my case back in gear,” said Lipari, adding, “her office also sent me another privacy waiver for an FBI investigation.”

Today the House Judiciary Committee will have the opportunity to question Mr. Gonzales.

We have a feeling that the questions for the Attorney General on Thursday morning will be somewhat tougher.

Maybe Chairman John Conyers will actually ask Gonzales what he knows about the five dead and fired U.S. attorneys probing Medicare fraud in Dallas Fort Worth and perhaps he will attempt to get to the bottom of Sam Lipari’s case.

The Bush-Clinton crime families have already stolen enough taxpayer funds from the U.S. Treasury; so it is hoped that the People’s House of Representatives will prevent further looting of Medicare and Medicaid funds so that America’s seniors will continue to be afforded proper medical care in their old age.

Federal whistleblower Mary Schneider contributed additional research for this report.

www.tomflocco.com

www.stewwebb.com

I found the original NYT article on the enormity of the healthcare fraud to be investigated on the Masimo company website as follows:

http://www.masimo.com/NYTimes/NYTimes_08212004.htm

Here is the article as found on the Masimo company page on October 19, 2013 and it kind of makes those investigations and prosecutions of fraudulent behaviors by clinics (fly by night and otherwise) look like small potatoes by comparison :


August 21, 2004

Wide U.S. Inquiry Into Purchasing for Health Care
By MARY WILLIAMS WALSH
The Justice Department has opened a broad criminal investigation of the medical-supply industry, apparently to determine whether hospitals and other medical care providers are fraudulently overcharging Medicare and other federal and state health programs for a wide array of goods – from rubber gloves to drugs to X-ray machines.More than a dozen medical-supply companies recently received federal subpoenas in what appears to be a wide-ranging investigation into the way suppliers market products to clinics, hospitals and nursing homes that serve Medicare and Medicaid patients, and whether those institutions properly account for the purchases.Industry executives expect many hospitals to receive similar requests in coming weeks.The central issue, according to current and former industry executives, is whether the industry’s use of rebates, discounts, barter arrangements and refunds to hospitals and other medical centers means that Medicare and Medicaid are being charged higher prices for products than the hospitals are actually spending.

The investigation appears to be centered on the medical-supply industry’s dealings with Novation, a company in Irving, Tex., that is an industry leader in negotiating the contracts that thousands of hospitals, clinics, nursing homes and other facilities use to buy drugs and other supplies.

About $20 billion a year in medical products and services are sold under contracts arranged by Novation, which is owned by about 2,200 of the hospitals and care centers that use its services. They include well-known medical centers like New York- Presbyterian Hospital, Yale-New Haven Health Services and Baylor Health Care System in Dallas.

Because Novation is the link between thousands of health facilities on one side, and hundreds of medical goods and services companies on the other, the scope of the federal investigation appears to be broad.

A Novation official confirmed this week that the company was recently served with a federal subpoena demanding that it produce documents.

“This matter is in the very early stages,” Novation’s senior vice president, Jody Hatcher, said in an e-mail reply to a reporter’s questions. “Novation will fully cooperate with the U.S. attorney’s office to provide the requested documents.” Mr. Hatcher did not characterize the type of documents sought.

Mr. Hatcher also cautioned against drawing any inferences from the subpoena’s references to various sections of the United States Code that deal with health care offenses.

“These subpoenas can be issued without any finding of misconduct,” he said. “It would be misleading to state or imply that Novation, or any of its constituents or vendors, has violated any of the statutes you referenced.”

Hospitals and clinics are financed with public money to a great degree, through programs like Medicare that reimburse many of the costs they incur in treating patients. If a hospital submits an erroneous cost report to Medicare, it can receive a larger reimbursement than it is due. If this is done knowingly, it can constitute Medicare fraud, which can carry fines and a 10-year prison sentence.

The federal investigation came to light after one medical products company, Becton, Dickinson, disclosed last week in its quarterly financial report that it had been served with a subpoena. Becton, Dickinson, the world’s largest maker of medical needles and syringes, said in the report that it believed its transactions with Novation had “fully complied with the law,” that it would cooperate and that it was not currently a target of the investigation.

Some of the other big companies to be served with subpoenas are the drug makers Merck, Bristol-Myers Squibb and Genentech; the G.E. Healthcare medical equipment unit of General Electric, and Cardinal Health, a big manufacturer and distributor of drugs and medical supplies.

Based on the federal codes cited in a copy of one of the subpoenas, investigators are seeking evidence of health care fraud, conspiracy to defraud the United States, theft or bribery involving programs receiving federal funds, obstruction of investigations and other possible violations. The subpoena was signed by Shannon Ross, criminal chief of the United States attorney’s office in Dallas.

A spokeswoman for that office declined to discuss the subpoenas or to confirm that an investigation was in progress, citing longstanding policy. Most of the companies also declined to discuss the matter, other than to say that they would cooperate with investigators.

Novation’s primary business is to pool the purchasing volume of about 2,200 hospitals, as well as thousands of nursing homes, clinics and physicians’ practices, and to use their collective power to negotiate contracts with suppliers at a discount. In many cases, the contracts offer special rebates to hospitals that meet certain purchasing targets. Although Novation is not well known outside the industry, it wields formidable power because it can open, or impede, access to a vast institutional market for health products.

Novation’s business practices, which were the subject of an investigation in 2002 by The New York Times, have drawn criticism from several parties , including the antitrust subcommittee of the Senate Judiciary Committee. The practices under scrutiny include questionable payments in the awarding of contracts and incomplete accounting of the rebates paid to hospitals and other medical centers.

The chairman and ranking member of the subcommittee, Mike DeWine, Republican of Ohio, and Herb Kohl, a Wisconsin Democrat, have been monitoring Novation and other companies involved in the group purchasing of health products. In hearings, they have expressed concerns about possible abuses and have publicly called on companies in the industry to adopt heightened ethics policies or risk tighter regulation. The subcommittee is expected to hold another hearing on the issue next month.

Novation has also been attacked by other companies, in past testimony to the subcommittee and through civil suits brought by small medical suppliers that accused it of freezing them out of a big share of the market for medical products. But until now, Novation was not known to have been named in a criminal investigation.

In July, Becton, Dickinson, paid $100 million to settle a lawsuit in which a smaller needle manufacturer accused it of working with Novation and other purchasing companies to freeze competitors out of the institutional market. Becton, Dickinson denied any improper behavior in that case, saying it settled to avoid protracted and costly litigation.

A spokesman for Premier Inc. of San Diego, the nation’s second-largest hospital purchasing company, said that Premier had not received a subpoena. Novation was created in 1998 as a joint venture of two networks of nonprofit hospitals, VHA Inc. of Irving, Tex., and University HealthSystem Consortium of Oak Brook, Ill. The two networks are cooperatives that also provide services like consulting and data analysis for their members.

VHA, the larger of the two networks, holds the larger stake in Novation. It is composed of about 1,400 nonprofit hospitals – about one-fourth of the nation’s total – and 800 other health facilities. Many of its members are small and relatively obscure, but some are large and well known. Besides New York-Presbyterian, Yale-New Haven and Baylor, they include Massachusetts General Hospital in Boston and the University of Pennsylvania Health System in Philadelphia. A spokesman for VHA referred questions about the investigation to Novation.

University HealthSystem Consortium is much smaller than VHA but consists of many prestigious teaching and research hospitals, including Johns Hopkins Hospital, N.Y.U. Medical Center, Mount Sinai Medical Center and various facilities of the State University of New York. Its hospitals are considered an extremely attractive market by suppliers, because they tend to perform unusual procedures and buy more high-end devices.

An official of University HealthSystem Consortium said that the organization had not been subpoenaed but that the consortium “would assist Novation in responding to the subpoena that they have received.”

People in the medical-supply business who were aware of the subpoenas said the investigators wanted records of payments made by suppliers to Novation and to the hospitals and other facilities that use its contracts.

“It’s about the money, and you’ve got to be able to track where the money goes,” said a former Novation executive, who would discuss Novation’s operations only anonymously because he was “concerned about being completely blackballed” in the industry.

The executive said he had been contacted by an investigator from the Department of Health and Human Services’ Office of Inspector General, who asked for the same type of information the Justice Department is seeking: the nature of the payments that suppliers make to Novation, how Novation picks which companies will be awarded contracts and what Novation does with the payments it receives from suppliers.

In most cases, suppliers are not permitted to make gifts or payments to purchasing agents for health facilities that receive Medicare money, because of the risk that some might offer kickbacks in their efforts to win business. But Novation operates within a “safe harbor” of the anti-kickback law, created specially for hospital purchasing groups.

The provision allows Novation to accept payments from suppliers with no legal consequence, as long as those payments do not exceed the safe-harbor limit, which is 3 percent of the suppliers’ sales through Novation’s contracts.

Over the years, these payments have become customary in the business. They are called administrative fees, because they are supposed to cover the cost of administering the contracts.

But industry records show that some companies have made other types of payments to Novation as well, and the total payments have sometimes exceeded the safe-harbor limit, sometimes surpassing 10 percent. Companies also contribute seed money to various initiatives and programs conducted by Novation’s parent, VHA, and to a related foundation, the VHA Health Foundation, which finances health-delivery projects undertaken in VHA hospitals.

Because businesses set up as cooperatives are barred from retaining capital, Novation and its two parent companies are required each year to distribute all of these payments to their member hospitals, after subtracting operating expenses. Those yearly distributions, as well as the rebates to hospitals that meet their purchasing contract targets and certain in-kind contributions, effectively lower the hospitals’ purchasing costs.

But because Novation is not publicly traded, there is no public accounting of these distributions. Some of the distributions are not made in cash, meanwhile, but in coupons that hospitals can use to purchase consulting services from VHA.

Hospital officials say privately that the complexity of these flows of funds makes it next to impossible to state the true costs of the drugs and other supplies they purchase each year, when they report their expenses to Medicare.

The former Novation executive said he believed that the federal investigators might see similarities in those arrangements to payments that drug companies have made to doctors who prescribed their brands – payments that have led to multibilliondollar settlements by some pharmaceutical companies.

“Pharmaceuticals are referred to in the press because the average reader can associate with them more,” the former executive said. “Consumers don’t buy operating-room tables or X-ray machines, or that kind of stuff, but you’ve got the same sort of thing going on. And it’s huge, huge money.”

© 2013 Masimo Corporation. All Rights Reserved.

Lipari’s attorney was subsequently targeted by the judiciary and disbarred. Coincidental? Or a way of obstructing first amendment rights?

Advertisements

Misdiagnosis by physicians: altering the healthcare costs in the USA

This post will review and post the writings I find most useful on the Internet on this issue.

Sandra Boodman   Washington Post health Writer   published in the National Center for Policy Analysis   ncpa.org   and previously published in the Kaiser Health News

From http://www.ncpa.org/sub/dpd/index.php?Article_ID=23148    as copied here

Physicians Misdiagnose at an Alarming Rate

May 8, 2013

Misdiagnosis by physicians is a serious and common occurrence in the health industry. The repercussions of a misdiagnosis can damage a patient’s health and cost money, or even a life. The prevalence of misdiagnosis is shocking, says Kaiser Health News.

  • An estimated 10 percent to 20 percent of cases are misdiagnosed, which exceeds drug errors and surgery on the wrong patient or body part, both of which receive considerably more attention.
  • One report found that 28 percent of 583 diagnostic mistakes were life threatening or had resulted in death or permanent disability.
  • Another study estimated that fatal diagnostic errors in U.S. intensive care units equal the number of breast cancer deaths each year — 40,500.

According to doctors, misdiagnosis has occurred for quite some time. As far back as 1991, Harvard University found that misdiagnosis accounted for 14 percent of all adverse events and that 75 percent of these errors involved negligence.

  • While the first diagnosis may not be the correct diagnosis, hospitals could still earn performance incentives for the “correct” diagnosis of its patients.
  • The reality is that fixing diagnostic errors will be challenging given that arriving upon a medical diagnosis is a complicated and multifaceted procedure.
  • Many doctors who make a misdiagnosis are unaware that they have made a misdiagnosis because patients simply seek another opinion or do not find out until years later.

While diagnostic errors are the leading cause of malpractice litigation, the vast majority of errors do not result in legal action. Because many go unreported, it is difficult to gather detailed data on how prevalent misdiagnosis is. A recent study on the Veterans Administration hospital system in Texas estimated that there are at least 500,000 missed diagnostic opportunities that occur out of the 500 million primary care visits that occur annually in the United States.

  • A survey found that 96 percent of physicians felt that diagnostic errors are preventable while half said they encountered at least one per month.
  • Despite these statistics, many doctors are reluctant to report diagnostic errors, even anonymously, despite the likelihood of moderate to severe harm on the patient.

Source: Sandra Boodman, “Doctors’ Diagnostic Errors Are Often Not Mentioned But Can Take a Serious Toll,” Kaiser Health News, May 6, 2013.

Barbara Boxer and other Congressional contacts

In case anyone thinks I haven’t tried, I have had contact with the federal employees at the offices of

Texas    Lamar Smith, Kay Bailey Hutchison

California   Pete Wilson, Barbara Boxer, Nancy Pelosi, Anna Eschoo, Barbara Lee, Henry Waxman

These interactions were in person except for Kay Bailey Hutchinson which was by telephone.

The documents I delivered to these other congressional offices, other than the one below, have not survived all the 4th amendment seizures of materials.

 

 

 

The following letter was faxed and then documented in       www.indybay.org/newsitems/2005/06/29/17501831.php‎ although it is archived ? because it doesn’t show up in google searches under just my name like other indybay articles do

Cynthia Lee, MD

Current resident: Texas

June 24, 2005
Via fax (to Sacramento office on June 25, 2005)

Barbara Boxer
United States Senator
1700 Montgomery Street, Suite 240
San Francisco, CA 94111

Dear Senator Boxer,

Late last year, I brought to your San Francisco office information I believed useful in regards to the pending battle over alterations to class action suit legislation. The information was accompanied by a book, The Promise of Sleep, by William Dement, MD., one of the eminent men of science of our day. I outlined how the pharmaceutical industry has hidden the true epidemic of obstructive sleep apnea from practicing physicians. Thus, physicians were taught to mislabel the symptoms of this disorder as other disorders that are commonly treated with prescription products. Since obstructive sleep apnea is not halted with prescription products, but rather it is stabilized by the use of an assistive breathing apparatus at night, undiagnosed these patients would have a progressive disorder resulting in early morbidity and mortality. I believe this is comparable to the tobacco industry’s cover-up of the health consequences of the use of their products. At this time, I am requesting that you advocate for a Department of Justice review of this issue much like they pursued the tobacco corporations.

While the high cost of prescription products is receiving much publicity, this issue is actually more important. This is because obstructive sleep apnea affects fully 1/4th of our middle aged white male population. Unbelievably, current estimates for the Black and Hispanic population are two to three times this rate. These men are at a higher risk than average for domestic abuse, criminal behavior, divorce, unemployment, cardiovascular complications like stroke and myocardial infarction, and most importantly, automobile accidents that endanger the others on the road. Obstructive sleep apnea patients cost a minimum of 150% of the average patients’ costs. You will find specialists in medicine who, after a cursory review of the available information, will state that I am mistaken. They will assert that middle aged white male patients with obstructive sleep apnea patients constitute only 4% of the population because this is what it states in textbooks. Unfortunately, this is not true. The original study that I am referring to was performed in Wisconsin and published in 1993 in the Journal of the American Medical Association. The 4% figure resulted from a survey questionnaire of the 24% of the patients with the minimum apnea results for the diagnosis. Only 1 out of 6 patients with enough apnea to carry the diagnosis of obstructive sleep apnea believed that they experienced sleepiness during the day. These patients have Sleep Apnea Syndrome; hence, the 4% figure was published. Since that study appeared , it has been clarified that the other 5 out of 6 patients who did not complain of sleepiness were, in fact, neurologically impaired for activities of daily living such that they have behavioral disorders, medical complications, and risky driving. Not counting these patients who do not complain of day time drowsiness is comparable to ignoring elevations of cardiac enzymes if the patient does not complain of chest pain bringing them to the physician’s attention.

While I understand the above discussion is a little bit to wade through, it underscores the importance of a core issue. State and federal governments have allowed the pharmaceutical industry to control physician education. The lectures and medical education information we physicians receive on behavioral issues leaves out information on sleep disorders. Since this is classified as CME units, I maintain that this has been an illegal behavior on the part of this industry. Many of our highly placed and influential physicians have been taken in by this pharmaceutical industry attempt to sway our education. Other have benefited from their largess so that they are unlikely to speak out. It is up to our legislators to intervene since the government has deliberately cut back physician educational funding, leaving the medical faculty and educational system vulnerable. Never the less, the behavior of pharmaceutical industry, in deliberately leaving out this clinical information, should occasion review for criminal behavior since it has resulted in early morbidity and mortality for many citizens. In others, it has created behavioral crises such that their judgment was so impaired that their conduct was criminal. Such may be the case for our Black and Hispanic population since their middle aged men carry 2 to 3 times the risk of having obstructive sleep than the Anglo middle aged male populations. On the issue of incarceration of persons with a diagnosis of obstructive sleep apnea, unsuspected, undiagnosed, and untreated, the Americans with Disability Act may be invoked to protect their right to experts unbiased by commercial education promoted by the pharmaceutical industry. Since these patients’ physicians never received the information timely to help them avoid antisocial behavior, the current system of allowing the pharmaceutical industry de facto control of physician education may render the current criminal justice system illegal.

Therefore, I urge you to advocate for a Department of Justice review utilizing the most knowledgeable experts. Since pharmaceutical industry influence over physician behavior may have caused the huge costs that our society bears, possibly as high as twice what other Western nations experience, this issue needs to be explored before physician independence is threatened by single payer system issues. By bringing the true diagnoses to light, we may be able to decrease the cost of all kinds of insurance affected by human behavior, from health, to worker’s comp, to automobile insurance. The savings may be able to allow an equitable single payer system to be considered favorably.

While I did not hear back from your office after my December 2004 submission, this may be because much of my U. S. mail has been delayed or never received at all since filing an Americans with Disability Act case in Texas. The phone number listed at that time was 512 XXX XXXX. If your office tried to call, I never received the call. If they believe they did speak with me, the call actually was handled by another not authorized to do so. I would be willing to volunteer with additional time and materials on this issue if desired. This information will also be sent registered mail to your office since it is so timely and I wish to document receipt.

Respectfully submitted,

Cynthia Jeanne Lee, MD

Cynthia Lee, MD

Physician Heroes of mine

This blog is where I am noting physicians who have had to stand up against the overwhelming forces that have an economic interest in physicians remaining ignorant. You may want to learn about them and pass on the praise.

John Dommisse MD was trained at a medical school where he learned about vitamin B12 being useful to stop dementia and psychotic aggression. This is fascinating to me because in one interview he noted he had had to spend a total of $250,000 to protect his medical license.* See his site here        http://www.johndommissemd.com/b12.html     I am recommending you open  up to his site where I think his discussion and defense of the science in how to interpret levels of vitamin B 12 will be useful in educating your physician or that of your friend or family member who wants to use neuroleptic medications for their behavior.

Terry Wahls MD is a professor of internal medicine at a medical school. She has multiple sclerosis. She had plenty of money, connections, insurance, and prescription drugs but progressed to non-ambulatory status anyway. She read on the basic science issues and changed her strategy, most importantly, her diet. Now she can ride her bicycle 5 miles to work and back. Read about her here.      http://www.terrywahls.com/

Her video about the process of discovery necessary to achieve this breakthrough is so very important to understand why this country is so underwater with medical costs.  I will find it and attach it (I already did this today but the work vanished not to be found)

William Rea MD is a leader in the field of environmental exposure illnesses. http://www.ehcd.com/about-our-professionals/

The Texas Medical Board originally went after this doctor because they do not believe in the concept of multiple chemical sensitivity, however, the U S government has recognized this syndrome as documented in wikipedia:

In 1997, U.S. Social Security Administration Commissioner John Callahan issued a court memorandum officially recognizing MCS “as a medically determinable impairment” on an agency-wide basis.[21] That is, without making any statement about the cause of MCS or the role of chemicals in MCS, the Social Security administration agrees that some MCS patients are too disabled to be meaningfully employed.[22]

The wikipedia I pulled this from is linked here: en.wikipedia.org/wiki/Multiple_chemical_sensitivity

OMG….ALL these physicians have had appointments at medical schools….could they just be that much brighter than your usual government licensing official?

*This use of the licensing issue and exorbitant legal fees was a technique used on me also. I would like Dr. Dommisse to be explicit on how the costs were generated and how he located his attorneys. I would like to understand if there were any similarities to the process of how I was set up with attorneys who actually represented the interests of others instead of me.

The blog I got the attorney financial scoop on is here: http://the-moneychanger.com/articles/what_you_dont_know_about_vitamin_b12_can_hurt_you

There are other physicians out there who have not spoken up. There may have been techniques even more fearsome than the threat of high legal fees.

%d bloggers like this: